Messages in brief

News

Registration of mail order pharmacies starts

messages in brief | 28/05/2015

Situation in Austria

As of June 25, 2015, remote sales of over-the-counter pharmaceutical specialties approved in Austria will be made possible.…

Registration of mail order pharmacies starts Read more
News

EMA questionnaire for children on the use of medicines and clinical trials

Safety warnings | messages in brief | 12/05/2015

Measures at EU level

The European Medicines Agency (EMA) would like to increase the acceptance of participation of children and adolescents in…

EMA questionnaire for children on the use of medicines and clinical trials Read more
News

Warning against use of new hepatitis C drugs with amiodarone

Safety warnings | messages in brief | 28/04/2015

The Federal Office informs about recommendations of the European Medicines Agency EMA regarding a restriction of the use of new hepatitis C drugs…

Warning against use of new hepatitis C drugs with amiodarone Read more
News

Results of review of generic approvals with respect to potentially falsified bioequivalence studies in India.

Safety warnings | messages in brief | 23/01/2015

Measures at EU level

An inspection at the research service provider GVK Biosciences in Hyderabad (India) revealed serious deficiencies in the…

Results of review of generic approvals with respect to potentially falsified bioequivalence studies in India. Read more
News

EU Commission releases "ellaOne" morning-after pill from prescription requirement

messages in brief | 15/01/2015

Measures at EU level The EU Commission has released the emergency contraceptive "ellaOne" (active ingredient: Ulipristal) from prescription-only…

EU Commission releases "ellaOne" morning-after pill from prescription requirement Read more
News

Safety information for the use of isotretinoin

Safety warnings | messages in brief | 04/01/2015

Isotretinoin is a highly effective vitamin A analogue that has been used since the early 1980s to treat severe, therapy-resistant forms of acne. When…

Safety information for the use of isotretinoin Read more
News

Review of generic approvals with regard to potentially falsified bioequivalence studies.

Safety warnings | messages in brief | 12/12/2014

An inspection by the French Medicines Agency (ANSM) of the research service provider GVK Biosciences in Hyderabad (India) has revealed serious…

Review of generic approvals with regard to potentially falsified bioequivalence studies. Read more
News

Falsified bioequivalence studies could lead to approval suspensions for individual generic drugs

Safety warnings | messages in brief | 06/12/2014

An inspection by the French Medicines Agency (ANSM) of the research service provider GVK Biosciences in Hyderabad (India) has revealed serious…

Falsified bioequivalence studies could lead to approval suspensions for individual generic drugs Read more
News

Deactivation of e-mail addresses "spc@ages.at" and "mrp-spc@ages.at for human medicines

messages in brief | 03/12/2014
As previously announced, the following e-mail addresses spc@ages.at and mrp-spc@ages.at are deactivated on 31.01.2014.

Austrian "Summaries of Product…
Deactivation of e-mail addresses "spc@ages.at" and "mrp-spc@ages.at for human medicines Read more
News

Italy: suspension of 2 batches of Fluad, Austria not affected

Safety warnings | messages in brief | 28/11/2014

Austria has been informed by the Italian Medicines Agency (AIFA) of a precautionary suspension of two batches (142701 and 143301) of the influenza…

Italy: suspension of 2 batches of Fluad, Austria not affected Read more
Email

Further inquiry note